SCHEMBL25218898

SCHEMBL25218898

Cc1cccc(NC(=O)c2nc(Cl)ccc2C)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 1/20 0.55
▸ LMNA P02545 2/20 0.55
▸ TP53 P04637 2/20 0.55
▸ KMT2A Q03164 5/20 0.54
▸ MEN1 O00255 4/20 0.54
▸ RXFP1 Q9HBX9 1/20 0.54
▸ SMN1; SMN2 Q16637 4/20 0.53
▸ ALDH1A1 P00352 3/20 0.53
▸ KDM4E B2RXH2 1/20 0.53
▸ MAPT P10636 1/20 0.53
▸ NPC1 O15118 3/20 0.51
▸ RAB9A P51151 2/20 0.51
▸ FLT3 P36888 1/20 0.51
▸ MAP4K1 Q92918 1/20 0.51
▸ KCNK3 O14649 3/20 0.50
▸ KCNK9 Q9NPC2 2/20 0.50
▸ SCN2A Q99250 1/20 0.50
▸ SCN10A Q9Y5Y9 1/20 0.50
▸ KCNH2 Q12809 1/20 0.50
▸ NPSR1 Q6W5P4 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30184168 1.00 GAA (0.55) GAALMNATP53KMT2AMEN1
SCHEMBL25592374 0.83 HTT (0.56) LMNAKMT2AMEN1RXFP1ALDH1A1
SCHEMBL30184289 0.83 HTT (0.56) LMNAKMT2AMEN1RXFP1ALDH1A1
SCHEMBL23413329 0.76 GAA (0.60) GAALMNATP53KMT2AMEN1
SCHEMBL30097611 0.76 GAA (0.60) GAALMNATP53KMT2AMEN1
SCHEMBL259296 0.75 KMT2A (0.80) GAALMNATP53KMT2AMEN1
SCHEMBL2064811 0.75 SCN2A (0.70) GAALMNATP53KMT2AMEN1
SCHEMBL25210996 0.74 AHR (0.56) LMNATP53KMT2AMEN1SMN1; SMN2
SCHEMBL18824684 0.74 CTSA (0.40) GAALMNAKMT2AMEN1SMN1; SMN2
SCHEMBL25590400 0.74 CLK2 (0.46) LMNATP53KMT2AMEN1RXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023088435-A1 PREPARATION FOR TRISUBSTITUTED PYRIDINE DERIVATIVE AND APPLICATION AS AROMATIC HYDROCARBON RECEPTOR MODULATOR 成都奥睿药业有限公司 2023-05-25 — — WO disclosed
CN-115785064-A Preparation of tri-substituted pyridine derivatives and their use as modulators of aromatic hydrocarbon receptors 成都奥睿药业有限公司 2023-03-14 — — CN disclosed
US-20170129906-A1 REACTIONS OF THIADIAZOLYL-OXIMINOACETIC ACID DERIVATIVE COMPOUNDS MERCK SHARP & DOHME CORP. (US) 2017-05-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170129906-A1 REACTIONS OF THIADIAZOLYL-OXIMINOACETIC ACID DERIVATIVE COMPOUNDS TST, DCTD, MLYCD GAA 1560/4885LMNA 4306/4885TP53 3060/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback